Menú

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Projectes

Group projects

Estudio posautorización de seguridad (EPAS) no intervencionista para la vigilancia activa de la seguridad de los receptores de la vacuna de ARNm contra la COVID-19 de Pfizer-BioNTech en la UE

  • Principal investigators: Sonia Olías Bretones, Cristina Alcaide Moreno, Felipe Villalobos Martínez
  • Code: 5O21/003
  • Start year: 2021

Plataforma IMPACT – Programa 1 Medicina Predictiva IMP/00021

  • Principal investigators: Anna Berenguera Ossó, Bonaventura Bolíbar Ribas, Josep Basora Gallisà
  • Code: 9F20/010
  • Start year: 2020
  • Funders: Consoricio Centro de Investigación Biomédica en RED (CIBER), Instituto de Salud Carlos III

Post-Authorisation Active Surveillance Study of Myocarditis and Pericarditis Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID 19) Vaccine

  • Principal investigators: Bonaventura Bolíbar Ribas, Felipe Villalobos Martínez
  • Code: 4R22/078
  • Start year: 2022
  • Funders: Fondazione Penta ETS

Clinical course, outcomes and risk factors of myocarditis following administration of mRNA-1273 (ELASOMERAN)

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R23/046
  • Start year: 2023
  • Funders: Julius Clinical Research B.V.

Self-controlled case series (SCCS) study of COVID-19 vaccines and myocarditis and pericarditis (GVDN-VAC4EU-Myocarditis)

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R22/215
  • Start year: 2022